Want to see ABUS full AI Analyst Report?
Arbutus Biopharma (ABUS) Income Statement
1,286 Followers
Arbutus Biopharma Income Statement
Last quarter (Q2 2026), Arbutus Biopharma's total revenue was $1.01M, a decrease of 90.56% from the same quarter last year. In Q2, Arbutus Biopharma's net income was $-5.14M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 14.08M | $ 6.17M | $ 18.14M | $ 39.02M | $ 10.99M | |
| $ 13.72M | $ 6.17M | $ 18.14M | $ 39.02M | $ 10.99M | |
| $ 40.77M | $ 82.49M | $ 96.24M | $ 104.47M | $ 84.51M | |
| Depreciation and Amortization | $ 363.00K | $ 1.38M | $ 1.40M | $ 1.43M | $ 1.75M |
| $ -33.04M | $ -68.40M | $ -70.99M | $ -61.86M | $ -71.64M | |
| $ -27.05M | $ -76.32M | $ -78.10M | $ -65.46M | $ -73.52M | |
| $ -6.45M | $ 6.40M | $ 5.25M | $ 444.00K | $ -2.73M | |
| $ -33.50M | $ -69.92M | $ -72.85M | $ -65.01M | $ -76.25M | |
| $ -33.50M | $ -69.92M | $ -72.85M | $ -69.46M | $ -76.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.17 | $ -0.38 | $ -0.44 | $ -0.46 | $ -0.73 |
| Diluted EPS | $ -0.17 | $ -0.38 | $ -0.44 | $ -0.46 | $ -0.73 |
| Weighted Average Shares Outstanding | 191.60M | 185.61M | 165.96M | 150.94M | 106.24M |
| Weighted Average Shares Outstanding (Diluted) | 191.60M | 185.61M | 165.96M | 150.94M | 106.24M |
Currency in USD
